MapLight Therapeutics, Inc.
MPLT
$16.14
$0.140.88%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -12.11% | -4.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 53.44% | 22.04% | |||
| Operating Income | -53.44% | -22.04% | |||
| Income Before Tax | -62.21% | -17.98% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -62.21% | -17.98% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -62.21% | -17.98% | |||
| EBIT | -53.44% | -22.04% | |||
| EBITDA | -54.09% | -22.11% | |||
| EPS Basic | -60.91% | -3.71% | |||
| Normalized Basic EPS | -58.36% | -3.71% | |||
| EPS Diluted | -60.91% | -3.71% | |||
| Normalized Diluted EPS | -58.36% | -3.71% | |||
| Average Basic Shares Outstanding | 0.81% | 13.76% | |||
| Average Diluted Shares Outstanding | 0.81% | 13.76% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||